本集探討：頭頸部癌症免疫治療

引用文獻：

1. Chang YC et al. Combination of immunotherapy and anti-EGFR agents in immunotherapy refractory HNSCC. Research Square 2026. DOI: 10.21203/rs.3.rs-9000074/v1

2. He R et al. TMEM92 drives EMT-associated invasiveness and immune suppression in HNSCC. Scientific Reports 2026. DOI: 10.1038/s41598-026-49694-7

3. Chen Y et al. Clinical Significance of Biomarkers in Oropharyngeal SCC. Cancer Reports 2026. DOI: 10.1002/cnr2.70539

4. Trabolsi A et al. Transferrin Receptor Overexpression in Solid Tumors. Cancers 2026. DOI: 10.3390/cancers18091402

5. Innovative biomaterial solutions for enhancing tumor immunotherapy. Immunologic Research 2026. DOI: 10.1007/s12026-026-09762-6

6. Association between antibiotic use and immunotherapy efficacy in ESCC. Int J Clinical Oncology 2026. DOI: 10.1007/s10147-026-03036-9

「ENT Update」— 每週專業耳鼻喉頭頸外科深度對談